Mobile Bearing Knees Get FDA Panel Nod For Class II; J&J Sees Competition
This article was originally published in The Gray Sheet
Executive Summary
Unicompartmental mobile bearing knees should be reclassified as Class II with special controls despite a lack of clinical safety data addressing implant wear and fracture, according to FDA's Orthopaedic & Rehabilitation Devices Panel